- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04831346
Effects of Low-Level Laser Therapy on Mouth Opening and Surface Electromyography in Temporomandibular Disorders
Effects of Low-Level Laser Therapy Versus Soft Occlusive Splints on Mouth Opening and Surface Electromyography in Temporomandibular Disorders
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
A prospective, parallel randomized, controlled study will be conducted at the outpatient university clinic. Participant recruitment started following approval from the Ethics Committee .The patients will participate in the study after signing an informed consent form prior to data collection. Per inclusion criteria, subjects included are females less than 30 years of age, diagnosed with unilateral arthrogenous TMD, having complete permanent dentition and showing normal occlusion. Prior to participating in any study-related procedures, participants read and signed the informed consent form approved by the Institutional Review Board. Participants will be divided into three groups; three groups: LLLT (Group A); soft occlusive splint therapy OST (Group B); waitlist as controls (Group C).
Outcome measures: TMJ opening index (TOI), VAS, sEMG. Participants were not given information on which treatment they were receiving; they were only told that they could receive one of two different treatment techniques. Sessions were scheduled 3 days a week (every other day) for a total of 10 sessions
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Tamer Shousha, Lecturer
- Telefonnummer: 002-01227900667
- E-Mail: shoushadoc@yahoo.com
Studienorte
-
-
-
Giza, Ägypten, 11432
- Rekrutierung
- Faculty of physical therapy
-
Kontakt:
- Tamer Shousha, Lecturer
- Telefonnummer: 002-01227900667
- E-Mail: shoushadoc@yahoo.com
-
Kontakt:
- Alaa Balbaa, Professor
- Telefonnummer: 002-01005167796
- E-Mail: balbaaa@hotmail.com
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
Females less than 30 years of age, Diagnosed with unilateral myogenous TMD, Having complete permanent dentition Showing normal occlusion
Exclusion Criteria:
Prior experience of Laser therapy, Systemic diseases (rheumatoid arthritis, ankylosing spondylitis, diabetes… etc. History of trauma in the TMJ or cervical regions; Neurological disorders, Muscular diseases; Cervical pain; Bruxism, Pregnancy; Currently on medication (analgesic, anti-inflammatory, muscle relaxants or anti- depressants) Current use of dental prosthetics; Previous orthodontal treatments; or Fixed restorations affecting occlusal surfaces.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: low level laser
A low-level gallium arsenide diode (Biolase, USA) at a 940 nm wavelength with 0.2 W output power and 2 J energy. The device was calibrated, and the probe was disinfected prior to every treatment. The Masseter and Temporalis muscles will be bilaterally assessed with constant pressure to define tenderness. LLLT applied perpendicular to each tender point of the intended muscles for 10 seconds with an energy density of 2.5 J/cm2. Sessions are scheduled 3 days a week (every other day) |
940 nm wavelength with 0.2 W output power and 2 J energy applied for 10 seconds with an energy density of 2.5 J/cm2.
Andere Namen:
|
Experimental: Occlusive splint therapy
A soft occlusal splint (vacuum-formed ) made from a 2-mm-thick elastic rubber sheets will be used. Splints were individually designed ( in the out patient clinic of the college of dentistry) for the upper arch of each patient. An alginate imprint of the maxillary arch will be taken to fabricate a master cast of the maxilla. A vacuum pressure device was utilized for molding the rubber sheets (13 x 13 cm /2-mm thickness). Sheets were removed after it has been appropriately adjusted to the mold in the vacuum former. Edges will be properly trimmed, and the palate part is detached to obtain the end shape. Participants are instructed to wear the splint at all times except during mealtimes and oral hygiene. |
A vacuum-formed soft occlusal splint made from a 2-mm-thick elastic rubber sheets. Participants are instructed to always wear the splint except during mealtimes and oral hygiene. |
Kein Eingriff: Control
This group will be a wait list group recieving no intervention except for the regular analgesic prescribed by the reffering dentist
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in the Temporomandibular joint opening index (TOI):
Zeitfenster: baseline (pre-treatment) / after 3 weeks / and after 1 year
|
Active and passive mouth opening will be assessed by a Boley gauge (Electronic Digital Caliper, CE Company, Japan) TOI= Passive opening mm -Maximum voluntary opening mm X 100 Passive opening mm +Maximum voluntary opening mm |
baseline (pre-treatment) / after 3 weeks / and after 1 year
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
change in surface EMG (sEMG):
Zeitfenster: baseline (pre-treatment) / after 3 weeks / and after 1 year
|
For recording, a surface electromyograph (Myotronics-Noromed, Inc., Tukwila WA, USA), with 8-channels, simultaneous acquisition, common grounding to all channels, and filters of 50 Hz electromyography with disposable electrodes will be used. Subjects will be seated on chairs with back and head rests to allow assessment from a relaxed position. The right masseter (RM), left masseter (LM), right anterior temporal (RAT), left anterior temporal (LAT), right sternocleidomastoid (RSM), and left sternocleidomastoid (LSM) muscles were recorded. The sEMG recordings and muscle activity will be expressed as the root mean square (rms) of the amplitude, expressed in µV. |
baseline (pre-treatment) / after 3 weeks / and after 1 year
|
Change in Visual Analogue Scale (VAS)
Zeitfenster: baseline (pre-treatment) / after 3 weeks / and after 1 year
|
The pain VAS is a reliable measure of pain intensity with a 10 centimeters (100 mm) continuous scale attached by 2 verbal descriptors, one for each symptom extreme. For pain intensity, the scale is most anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100). The VAS only requires the ability to use a ruler to measure the distance to determine a score. |
baseline (pre-treatment) / after 3 weeks / and after 1 year
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Tamer Shousha, lecturer
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Schmerzen
- Neurologische Manifestationen
- Erkrankungen des Bewegungsapparates
- Muskelerkrankungen
- Stomatognathe Erkrankungen
- Kiefererkrankungen
- Kraniomandibuläre Erkrankungen
- Unterkiefererkrankungen
- Myofasziale Schmerzsyndrome
- Gelenkerkrankungen
- Erkrankungen des Kiefergelenks
- Temporomandibuläres Dysfunktionssyndrom
- Gesichtsschmerzen
Andere Studien-ID-Nummern
- CairoU2020
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Low level laser
-
Lithuanian University of Health SciencesResearch Council of LithuaniaAbgeschlossenPlantarfasziitis | AchillessehnenschmerzenLitauen
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnbekanntNierenversagen, chronisch
-
Federal University of Health Science of Porto AlegreAbgeschlossenNiereninsuffizienz, chronisch | Nierendialyse | Low-Level-Lichttherapie | Klinische StudieBrasilien
-
St. Elisabethen Krankenhaus Frankfurt GmbHRekrutierungChirurgisches Narbengewebe eines Kaiserschnitts oder eines Vaginalrisses oder einer EpisiotomieDeutschland
-
University of Nove de JulhoSimone Aparecida Penimpedo Calamita; Fabiana Sarilho de Mendonça; Daniela Aparecida... und andere MitarbeiterAbgeschlossen
-
University of BergenAbgeschlossen
-
University of BergenNorwegian Fund for Postgraduate Training in PhysiotherapyAbgeschlossen
-
University of Texas Southwestern Medical CenterBeendetLow-Level-Lasertherapie mit physikalischer Therapie bei chronischen Schmerzen des BewegungsapparatesChronischer SchmerzVereinigte Staaten
-
University of OttawaBioFlexTM Laser TherapyAbgeschlossenProvozierte VestibulodynieKanada
-
NYU Langone HealthAbgeschlossenBrustkrebs | LymphödemVereinigte Staaten